DRIO Valuation

DarioHealth Corp

Add to Watchlist

Advanced Chart

7.780

+1.18(17.879%)1D

Overview
Forecast
Valuation
Earnings

DRIO Relative Valuation

DRIO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DRIO is overvalued; if below, it's undervalued.

Historical Valuation

DarioHealth Corp (DRIO) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.53 is considered Undervalued compared with the five-year average of -2.35. The fair price of DarioHealth Corp (DRIO) is between 44.65 to 135.34 according to relative valuation methord. Compared to the current price of 7.78 USD , DarioHealth Corp is Undervalued By 82.57%.

Relative Value

Fair Zone

44.65-135.34

Current Price：7.78

82.57%

Undervalued

-0.54

Trailing

Forward

-1.67

EV/EBITDA

DarioHealth Corp. (DRIO) has a current EV/EBITDA of -1.67. The 5-year average EV/EBITDA is -2.95. The thresholds are as follows: Strongly Undervalued below -6.22, Undervalued between -6.22 and -4.58, Fairly Valued between -1.31 and -4.58, Overvalued between -1.31 and 0.32, and Strongly Overvalued above 0.32. The current Forward EV/EBITDA of -1.67 falls within the Historic Trend Line -Fairly Valued range.

-1.04

EV/EBIT

DarioHealth Corp. (DRIO) has a current EV/EBIT of -1.04. The 5-year average EV/EBIT is -1.74. The thresholds are as follows: Strongly Undervalued below -4.24, Undervalued between -4.24 and -2.99, Fairly Valued between -0.48 and -2.99, Overvalued between -0.48 and 0.77, and Strongly Overvalued above 0.77. The current Forward EV/EBIT of -1.04 falls within the Historic Trend Line -Fairly Valued range.

0.53

DarioHealth Corp. (DRIO) has a current PS of 0.53. The 5-year average PS is 4.36. The thresholds are as follows: Strongly Undervalued below -3.36, Undervalued between -3.36 and 0.50, Fairly Valued between 8.22 and 0.50, Overvalued between 8.22 and 12.08, and Strongly Overvalued above 12.08. The current Forward PS of 0.53 falls within the Historic Trend Line -Fairly Valued range.

-1.08

P/OCF

DarioHealth Corp. (DRIO) has a current P/OCF of -1.08. The 5-year average P/OCF is -3.47. The thresholds are as follows: Strongly Undervalued below -8.67, Undervalued between -8.67 and -6.07, Fairly Valued between -0.87 and -6.07, Overvalued between -0.87 and 1.73, and Strongly Overvalued above 1.73. The current Forward P/OCF of -1.08 falls within the Historic Trend Line -Fairly Valued range.

-0.43

P/FCF

DarioHealth Corp. (DRIO) has a current P/FCF of -0.43. The 5-year average P/FCF is -3.12. The thresholds are as follows: Strongly Undervalued below -7.60, Undervalued between -7.60 and -5.36, Fairly Valued between -0.88 and -5.36, Overvalued between -0.88 and 1.36, and Strongly Overvalued above 1.36. The current Forward P/FCF of -0.43 falls within the Overvalued range.

DarioHealth Corp (DRIO) has a current Price-to-Book (P/B) ratio of 0.23. Compared to its 3-year average P/B ratio of 0.79 , the current P/B ratio is approximately -70.49% higher. Relative to its 5-year average P/B ratio of 1.52, the current P/B ratio is about -84.54% higher. DarioHealth Corp (DRIO) has a Forward Free Cash Flow (FCF) yield of approximately -169.97%. Compared to its 3-year average FCF yield of -87.63%, the current FCF yield is approximately 93.95% lower. Relative to its 5-year average FCF yield of -61.54% , the current FCF yield is about 176.18% lower.

0.28

P/B

Median3y

0.79

Median5y

1.52

-169.97

FCF Yield

Median3y

-87.63

Median5y

-61.54

Competitors Valuation Multiple

The average P/S ratio for DRIO's competitors is 0.00, providing a benchmark for relative valuation. DarioHealth Corp Corp (DRIO) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -14.16%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Nexalin Technology Inc

Allurion Technologies Inc

SINTX Technologies Inc

Loss

-82.42%

12.99M

Performance Decomposition

Market capitalization of DRIO decreased by 65.27% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -217.59 to -241.94.

The secondary factor is the Revenue Growth, contributed -14.16%to the performance.

Overall, the performance of DRIO in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-14.16%

6.26M → 5.37M

Revenue Growth

11.19%

-217.59 → -241.94

Margin Expansion

-62.30%

-1.57 → -0.59

P/E Change

-65.27%